SCHEMBL1003039

SCHEMBL1003039

CC(C)CCC[Si](C)(O[Si](C)(C)C)O[Si](C)(C)C

nearest known ligand 0.35

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26453035 0.89 LMNA (0.31) LMNA
SCHEMBL727130 0.85
SCHEMBL2493718 0.81 LMNA (0.35) LMNA
SCHEMBL15797631 0.78 LMNA (0.36) LMNA
SCHEMBL786933 0.77
SCHEMBL25532072 0.76
SCHEMBL12029101 0.76 ALDH1A1 (0.35)
SCHEMBL9442191 0.74 LMNA (0.33) LMNA
SCHEMBL12220704 0.73 ALDH1A1 (0.34)
SCHEMBL2773252 0.73

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 88 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103642241-A Silicone composition MOMENTIVE PERFORMANCE MAT INC 2014-03-19 CN claimed
US-8017687-B2 Swollen silicone composition and process of producing same MOMENTIVE PERFORMANCE MATERIALS INC. (US) 2011-09-13 US claimed
EP-2228053-A1 Swollen silicone composition and process of producing same Momentive Performance Materials Inc. (US) 2010-09-15 EP claimed
US-20100003201-A1 Silicone composition MOMENTIVE PERFORMANCE MATERIALS, INC. 2010-01-07 US claimed
JP-2009516024-A 2009-04-16 JP claimed
EP-1968533-A1 SWOLLEN SILICONE COMPOSITION AND PROCESS OF PRODUCING SAME Momentive Performance Materials Inc. (US) 2008-09-17 EP claimed
EP-1962791-A1 SWOLLEN SILICONE COMPOSITION, PROCESS OF PRODUCING SAME AND PRODUCTS THEREOF Momentive Performance Materials Inc. (US) 2008-09-03 EP claimed
US-20070160547-A1 Method of applying a composition MOMENTIVE PERFORMANCE MATERIALS INC. 2007-07-12 US claimed
WO-2007061623-A1 SWOLLEN SILICONE COMPOSITION, PROCESS OF PRODUCING SAME AND PRODUCTS THEREOF MOMENTIVE PERFORMANCE MATERIALS INC. (US) 2007-05-31 WO claimed
WO-2007058825-A1 SWOLLEN SILICONE COMPOSITION AND PROCESS OF PRODUCING SAME MOMENTIVE PERFORMANCE MATERIALS INC. (US) 2007-05-24 WO claimed
US-20070112146-A1 Swollen silicone composition, process of producing same and products thereof MOMENTIVE PERFORMANCE MATERIALS INC. 2007-05-17 US claimed
US-20070112112-A1 Swollen silicone composition and process of producing same MOMENTIVE PERFORMANCE MATERIALS INC. 2007-05-17 US claimed
US-20040197284-A1 Cosmetic composition comprising a volatile fatty phase L'OREAL S.A. (FR) 2004-10-07 US claimed
EP-3768762-B1 SILICONE POLYMER MOMENTIVE PERFORMANCE MAT INC (US) 2025-02-19 EP disclosed
EP-3558222-B1 WATER-IN-OIL EMULSION COMPRISING A PARTICULAR EMULSIFYING SYSTEM, A LIPOPHILIC CLAY, AND AN ORGANOPOLYSILOXANE ELASTOMER POWDER COATED WITH A SILICONE RESIN OREAL (FR) 2024-04-03 EP disclosed
EP-3558238-B1 COMPOSITION CONTAINING AN OILY CONTINUOUS PHASE, A LIQUID DIPHENYLACRYLATE UV-SCREENING AGENT, A LIQUID SALICYLATE UV-SCREENING AGENT AND A NON-CYCLIC VOLATILE SILICONE OIL OREAL (FR) 2023-08-23 EP disclosed
WO-2007058825-A1 SWOLLEN SILICONE COMPOSITION AND PROCESS OF PRODUCING SAME MOMENTIVE PERFORMANCE MATERIALS INC. (US) 2007-05-24 WO disclosed
US-20070112146-A1 Swollen silicone composition, process of producing same and products thereof MOMENTIVE PERFORMANCE MATERIALS INC. 2007-05-17 US disclosed
US-20070112112-A1 Swollen silicone composition and process of producing same MOMENTIVE PERFORMANCE MATERIALS INC. 2007-05-17 US disclosed
US-20040197284-A1 Cosmetic composition comprising a volatile fatty phase L'OREAL S.A. (FR) 2004-10-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100003201-A1 Silicone composition CUTA, SMURF1, MMS19 LMNA 339/4885
US-20070112146-A1 Swollen silicone composition, process of producing same and products thereof PIEZO1, SMS, ALG3 LMNA 1739/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.